Intelligent Bio Solutions INBS
NASDAQ INBS
$2.61 -0.04 (-1.51%)
As of: Aug 21, 2026 · 10:52 AM EDT

Intelligent Bio Solutions Inc. (INBS) EBIT Margin (2019 - 2025)

Intelligent Bio Solutions (INBS) posted quarterly EBIT Margin of 351.28% for Q1 2025, up 727.0% year-over-year from 42.48% in Q1 2024, and up 5.76% quarter-over-quarter from 372.76% in Q4 2024.

Intelligent Bio Solutions Inc. (INBS) EBIT Margin (2019 - 2025) Analysis & Trends

Intelligent Bio Solutions' EBIT Margin history runs 7 years deep, the most recent figure standing at 351.28% for Q1 2025.

  • In Q1 2025, EBIT Margin rose 727.0% year-over-year to 351.28%; the TTM figure through Mar 2025 stood at 341.7% (up 1818.0% YoY), while the FY2023 annual figure was 1002.11%, down 46914.0% from the prior year.
  • EBIT Margin for Q1 2025 stood at 351.28%, up from 372.76% in the prior quarter.
  • The five-year high for EBIT Margin was 174.89% in Q2 2022, with the low at 9158.69% in Q1 2021.
  • The 5-year median for EBIT Margin is 358.55% (2024), against an average of 1143.01%.
  • The sharpest annual moves came in 2021 and 2022: EBIT Margin sank 727846 bps in 2021, then jumped 846112 bps in 2022.
  • Intelligent Bio Solutions' EBIT Margin stood at 1949.84% in 2021, then jumped by 69 bps to 597.45% in 2022, then soared by 56 bps to 260.63% in 2023, then tumbled by 43 bps to 372.76% in 2024, then climbed by 6 bps to 351.28% in 2025.
  • Business Quant data shows INBS's EBIT Margin at 351.28% in Q1 2025, 372.76% in Q4 2024, and 312.43% in Q3 2024.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2025 -351.28%
Dec 31, 2024 -372.76%
Sep 30, 2024 -312.43%
Mar 31, 2024 -358.55%
Dec 31, 2023 -260.63%
Sep 30, 2023 -317.35%
Jun 30, 2023 -609.86%
Mar 31, 2023 -1,431.63%
Dec 31, 2022 -597.45%
Sep 30, 2022 -350.62%
Jun 30, 2022 -174.89%
Mar 31, 2022 -697.57%
Dec 31, 2021 -1,949.84%
Jun 30, 2021 -201.67%
Mar 31, 2021 -9,158.69%
Dec 31, 2020 -324.10%
Sep 30, 2020 -1,196.16%
Jun 30, 2020 -737.53%
Mar 31, 2020 -1,880.23%
Dec 31, 2019 -213,523.18%